{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:34:01Z","timestamp":1790393641798,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11899-022-00663-7","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:03:14Z","timestamp":1654689794000},"page":"94-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies"],"prefix":"10.1007","volume":"17","author":[{"given":"Ryan J.","family":"Stubbins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Korotev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-9158","authenticated-orcid":false,"given":"Lucy A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"issue":"10","key":"663_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.exphem.2016.06.253","volume":"44","author":"BM Moehrle","year":"2016","unstructured":"Moehrle BM, Geiger H. Aging of hematopoietic stem cells: DNA damage and mutations? Exp Hematol. 2016;44(10):895\u2013901.","journal-title":"Exp Hematol"},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fmolb.2020.00024","volume":"7","author":"AC V\u00edtor","year":"2020","unstructured":"V\u00edtor AC, Huertas P, Legube G, de Almeida SF. Studying DNA double-strand break repair: an ever-growing toolbox. Front Mol Biosci. 2020;7:24.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"663_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/genes6020267","volume":"6","author":"C Gelot","year":"2015","unstructured":"Gelot C, Magdalou I, Lopez BS. Replication stress in mammalian cells and its consequences for mitosis. Genes (Basel). 2015;6(2):267\u201398.","journal-title":"Genes (Basel)"},{"issue":"7673","key":"663_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature24023","volume":"549","author":"N Arnoult","year":"2017","unstructured":"Arnoult N, Correia A, Ma J, Merlo A, Garcia-Gomez S, Maric M, et al. Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN. Nature. 2017;549(7673):548\u201352.","journal-title":"Nature"},{"issue":"3","key":"663_CR5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1083\/jcb.201806197","volume":"218","author":"HM Chow","year":"2019","unstructured":"Chow HM, Cheng A, Song X, Swerdel MR, Hart RP, Herrup K. ATM is activated by ATP depletion and modulates mitochondrial function through NRF1. J Cell Biol. 2019;218(3):909\u201328.","journal-title":"J Cell Biol"},{"issue":"13","key":"663_CR6","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1134\/S0006297916130058","volume":"81","author":"SV Khoronenkova","year":"2016","unstructured":"Khoronenkova SV. Mechanisms of non-canonical activation of ataxia telangiectasia mutated. Biochemistry (Mosc). 2016;81(13):1669\u201375.","journal-title":"Biochemistry (Mosc)"},{"issue":"13","key":"663_CR7","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1073\/pnas.1416031112","volume":"112","author":"SV Khoronenkova","year":"2015","unstructured":"Khoronenkova SV, Dianov GL. ATM prevents DSB formation by coordinating SSB repair and cell cycle progression. Proc Natl Acad Sci U S A. 2015;112(13):3997\u20134002.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev-biochem-060614-034335","volume":"84","author":"TT Paull","year":"2015","unstructured":"Paull TT. Mechanisms of ATM Activation. Annu Rev Biochem. 2015;84:711\u201338.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"663_CR9","doi-asserted-by":"publisher","first-page":"101972","DOI":"10.1016\/j.isci.2020.101972","volume":"24","author":"AJ Yeo","year":"2021","unstructured":"Yeo AJ, Chong KL, Gatei M, Zou D, Stewart R, Withey S, et al. Impaired endoplasmic reticulum-mitochondrial signaling in ataxia-telangiectasia. iScience. 2021;24(1):101972.","journal-title":"iScience"},{"issue":"1","key":"663_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121(1):25\u201333.","journal-title":"Cancer"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"4986365","DOI":"10.1155\/2020\/4986365","volume":"2020","author":"C Messina","year":"2020","unstructured":"Messina C, Cattrini C, Soldato D, Vallome G, Caffo O, Castro E, et al. BRCA mutations in prostate cancer: prognostic and predictive implications. J Oncol. 2020;2020:4986365.","journal-title":"J Oncol"},{"issue":"18","key":"663_CR12","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","volume":"373","author":"J Mateo","year":"2015","unstructured":"Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, et al. DNA-repair defects and olaparib in metastatic prostate cancer. N Engl J Med. 2015;373(18):1697\u2013708.","journal-title":"N Engl J Med"},{"issue":"1","key":"663_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7\u201317.","journal-title":"Gut"},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells9122675","volume":"9","author":"L Stolarova","year":"2020","unstructured":"Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, et al. Germline variants in cancer predisposition: stalemate rather than checkmate. Cells. 2020;9:12.","journal-title":"Cells"},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"19050","DOI":"10.1038\/srep19050","volume":"6","author":"L Cara","year":"2016","unstructured":"Cara L, Baitemirova M, Follis J, Larios-Sanz M, Ribes-Zamora A. The ATM- and ATR-related SCD domain is over-represented in proteins involved in nervous system development. Sci Rep. 2016;6:19050.","journal-title":"Sci Rep"},{"issue":"9","key":"663_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cancergen.2016.08.005","volume":"209","author":"TP Leedom","year":"2016","unstructured":"Leedom TP, LaDuca H, McFarland R, Li S, Dolinsky JS, Chao EC. Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers. Cancer Genet. 2016;209(9):403\u20137.","journal-title":"Cancer Genet"},{"issue":"4","key":"663_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0145-2126(00)00130-2","volume":"25","author":"WK Hofmann","year":"2001","unstructured":"Hofmann WK, Miller CW, Tsukasaki K, Tavor S, Ikezoe T, Hoelzer D, et al. Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias. Leuk Res. 2001;25(4):333\u20138.","journal-title":"Leuk Res"},{"issue":"4","key":"663_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1947601911413466","volume":"2","author":"D Malkin","year":"2011","unstructured":"Malkin D. Li-fraumeni syndrome. Genes Cancer. 2011;2(4):475\u201384.","journal-title":"Genes Cancer"},{"issue":"1","key":"663_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/jmedgenet-2019-106189","volume":"57","author":"F Fostira","year":"2020","unstructured":"Fostira F, Kostantopoulou I, Apostolou P, Papamentzelopoulou MS, Papadimitriou C, Faliakou E, et al. One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene. J Med Genet. 2020;57(1):53\u201361.","journal-title":"J Med Genet"},{"issue":"5","key":"663_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","volume":"375","author":"CC Pritchard","year":"2016","unstructured":"Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med. 2016;375(5):443\u201353.","journal-title":"N Engl J Med"},{"issue":"9","key":"663_CR21","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","volume":"4","author":"MI Carlo","year":"2018","unstructured":"Carlo MI, Mukherjee S, Mandelker D, Vijai J, Kemel Y, Zhang L, et al. Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma. JAMA Oncol. 2018;4(9):1228\u201335.","journal-title":"JAMA Oncol"},{"issue":"1","key":"663_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13053-015-0030-5","volume":"13","author":"M Kaczmarek-Ry\u015b","year":"2015","unstructured":"Kaczmarek-Ry\u015b M, Ziemnicka K, Hryhorowicz ST, G\u00f3rczak K, Hoppe-Go\u0142\u0119biewska J, Skrzypczak-Zieli\u0144ska M, et al. The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population. Hered Cancer Clin Pract. 2015;13(1):8.","journal-title":"Hered Cancer Clin Pract"},{"key":"663_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejca.2017.05.045","volume":"83","author":"BW Katona","year":"2017","unstructured":"Katona BW, Yang YX. Colorectal cancer risk associated with the CHEK2 1100delC variant. Eur J Cancer. 2017;83:103\u20135.","journal-title":"Eur J Cancer"},{"key":"663_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-021-00278-6","author":"Y Laitman","year":"2021","unstructured":"Laitman Y, Nielsen SM, Hatchell KE, Truty R, Bernstein-Molho R, Esplin ED, et al. Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant. Fam Cancer. 2021. https:\/\/doi.org\/10.1007\/s10689-021-00278-6.","journal-title":"Fam Cancer"},{"issue":"3","key":"663_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3324\/haematol.2011.049494","volume":"97","author":"H Janiszewska","year":"2012","unstructured":"Janiszewska H, Bak A, Pilarska M, Heise M, Junkiert-Czarnecka A, Kuliszkiewicz-Janus M, et al. A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations. Haematologica. 2012;97(3):366\u201370.","journal-title":"Haematologica"},{"issue":"1","key":"663_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/bjh.13559","volume":"173","author":"H Janiszewska","year":"2016","unstructured":"Janiszewska H, B\u0105k A, Hartwig M, Kuliszkiewicz-Janus M, Ca\u0142becka M, Ja\u017awiec B, et al. The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera. Br J Haematol. 2016;173(1):150\u20132.","journal-title":"Br J Haematol"},{"issue":"7831","key":"663_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-020-2786-7","volume":"586","author":"EL Bao","year":"2020","unstructured":"Bao EL, Nandakumar SK, Liao X, Bick AG, Karjalainen J, Tabaka M, et al. Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells. Nature. 2020;586(7831):769\u201375.","journal-title":"Nature"},{"issue":"8","key":"663_CR28","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","volume":"128","author":"DA Hinds","year":"2016","unstructured":"Hinds DA, Barnholt KE, Mesa RA, Kiefer AK, Do CB, Eriksson N, et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood. 2016;128(8):1121\u20138.","journal-title":"Blood"},{"key":"663_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.leukres.2018.05.013","volume":"70","author":"H Janiszewska","year":"2018","unstructured":"Janiszewska H, B\u0105k A, Skonieczka K, Ja\u015bkowiec A, Kie\u0142bi\u0144ski M, Jachalska A, et al. Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML. Leuk Res. 2018;70:74\u20138.","journal-title":"Leuk Res"},{"issue":"11","key":"663_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0145-2126(02)00075-9","volume":"26","author":"D Aktas","year":"2002","unstructured":"Aktas D, Arno MJ, Rassool F, Mufti GJ. Analysis of CHK2 in patients with myelodysplastic syndromes. Leuk Res. 2002;26(11):985\u20137.","journal-title":"Leuk Res"},{"issue":"4","key":"663_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.hemonc.2019.11.004","volume":"13","author":"MJ Sharifi","year":"2020","unstructured":"Sharifi MJ, Zaker F, Nasiri N, Yaghmaie M. Epigenetic changes in FOXO3 and CHEK2 genes and their correlation with clinicopathological findings in myelodysplastic syndromes. Hematol Oncol Stem Cell Ther. 2020;13(4):214\u20139.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"22","key":"663_CR32","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/onc.2009.69","volume":"28","author":"S Boehrer","year":"2009","unstructured":"Boehrer S, Ad\u00e8s L, Tajeddine N, Hofmann WK, Kriener S, Bug G, et al. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene. 2009;28(22):2205\u201318.","journal-title":"Oncogene"},{"issue":"5","key":"663_CR33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.exphem.2007.01.054","volume":"35","author":"O Hopfer","year":"2007","unstructured":"Hopfer O, Komor M, Koehler IS, Schulze M, Hoelzer D, Thiel E, et al. DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation. Exp Hematol. 2007;35(5):712\u201323.","journal-title":"Exp Hematol"},{"issue":"14","key":"663_CR34","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.4161\/cc.10.14.16399","volume":"10","author":"S Th\u00e9pot","year":"2011","unstructured":"Th\u00e9pot S, Lainey E, Cluzeau T, S\u00e9bert M, Leroy C, Ad\u00e8s L, et al. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell Cycle. 2011;10(14):2323\u201330.","journal-title":"Cell Cycle"},{"key":"663_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01246-w","author":"D Singhal","year":"2021","unstructured":"Singhal D, Hahn CN, Feurstein S, Wee LYA, Moma L, Kutyna MM, et al. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leukemia. 2021. https:\/\/doi.org\/10.1038\/s41375-021-01246-w.","journal-title":"Leukemia"},{"issue":"2","key":"663_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/cncr.29615","volume":"122","author":"JE Churpek","year":"2016","unstructured":"Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, et al. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer. 2016;122(2):304\u201311.","journal-title":"Cancer"},{"issue":"6","key":"663_CR37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjh.15265","volume":"184","author":"G Berger","year":"2019","unstructured":"Berger G, van den Berg E, Smetsers S, Leegte BK, Sijmons RH, Abbott KM, et al. Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations. Br J Haematol. 2019;184(6):1071\u20133.","journal-title":"Br J Haematol"},{"issue":"7","key":"663_CR38","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jmedgenet-2018-105824","volume":"57","author":"T Paperna","year":"2020","unstructured":"Paperna T, Sharon-Shwartzman N, Kurolap A, Goldberg Y, Moustafa N, Carasso Y, et al. Homozygosity for CHEK2 p.Gly167Arg leads to a unique cancer syndrome with multiple complex chromosomal translocations in peripheral blood karyotype. J Med Genet. 2020;57(7):500\u20134.","journal-title":"J Med Genet"},{"issue":"8","key":"663_CR39","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1182\/blood.2021011354","volume":"139","author":"F Yang","year":"2022","unstructured":"Yang F, Long N, Anekpuritanang T, Bottomly D, Savage JC, Lee T, et al. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult AML patients. Blood. 2022;139(8):1208\u201321.","journal-title":"Blood"},{"key":"663_CR40","doi-asserted-by":"publisher","first-page":"e2308","DOI":"10.1038\/cddis.2016.115","volume":"7","author":"A di Masi","year":"2016","unstructured":"di Masi A, Cilli D, Berardinelli F, Talarico A, Pallavicini I, Pennisi R, et al. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL. Cell Death Dis. 2016;7:e2308.","journal-title":"Cell Death Dis"},{"issue":"4","key":"663_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/path.2126","volume":"211","author":"A Varadaraj","year":"2007","unstructured":"Varadaraj A, Dovey CL, Laredj L, Ferguson B, Alexander CE, Lubben N, et al. Evidence for the receipt of DNA damage stimuli by PML nuclear domains. J Pathol. 2007;211(4):471\u201380.","journal-title":"J Pathol"},{"issue":"36","key":"663_CR42","doi-asserted-by":"publisher","first-page":"26645","DOI":"10.1074\/jbc.M604391200","volume":"281","author":"S Yang","year":"2006","unstructured":"Yang S, Jeong JH, Brown AL, Lee CH, Pandolfi PP, Chung JH, et al. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation. J Biol Chem. 2006;281(36):26645\u201354.","journal-title":"J Biol Chem"},{"issue":"27","key":"663_CR43","doi-asserted-by":"publisher","first-page":"18969","DOI":"10.1074\/jbc.M800560200","volume":"283","author":"A Yoda","year":"2008","unstructured":"Yoda A, Toyoshima K, Watanabe Y, Onishi N, Hazaka Y, Tsukuda Y, et al. Arsenic trioxide augments Chk2\/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase. J Biol Chem. 2008;283(27):18969\u201379.","journal-title":"J Biol Chem"},{"issue":"11","key":"663_CR44","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1182\/blood-2002-07-2311","volume":"101","author":"D Amico","year":"2003","unstructured":"Amico D, Barbui AM, Erba E, Rambaldi A, Introna M, Golay J. Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3. Blood. 2003;101(11):4589\u201397.","journal-title":"Blood"},{"issue":"10","key":"663_CR45","doi-asserted-by":"publisher","first-page":"e0140819","DOI":"10.1371\/journal.pone.0140819","volume":"10","author":"O Havranek","year":"2015","unstructured":"Havranek O, Kleiblova P, Hojny J, Lhota F, Soucek P, Trneny M, et al. Association of germline CHEK2 gene variants with risk and prognosis of non-Hodgkin lymphoma. PLoS One. 2015;10(10):e0140819.","journal-title":"PLoS One"},{"issue":"2","key":"663_CR46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2005-12-5022","volume":"108","author":"MF Rudd","year":"2006","unstructured":"Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood. 2006;108(2):638\u201344.","journal-title":"Blood"},{"issue":"1","key":"663_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10689-020-00192-3","volume":"20","author":"AJ Scott","year":"2021","unstructured":"Scott AJ, Tokaz MC, Jacobs MF, Chinnaiyan AM, Phillips TJ, Wilcox RA. Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series. Fam Cancer. 2021;20(1):61\u20135.","journal-title":"Fam Cancer"},{"issue":"12","key":"663_CR48","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1080\/10428190600942462","volume":"47","author":"GS Sellick","year":"2006","unstructured":"Sellick GS, Sullivan K, Catovsky D, Houlston RS. CHEK2*1100delC and risk of chronic lymphocytic leukemia. Leuk Lymphoma. 2006;47(12):2659\u201360.","journal-title":"Leuk Lymphoma"},{"key":"663_CR49","doi-asserted-by":"crossref","unstructured":"Bahassi EM, Robbins SB, Yin M, Boivin GP, Kuiper R, van Steeg H, et al. Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias. Proc Natl Acad Sci. 2009;106(40):17111\u20136.","DOI":"10.1073\/pnas.0909237106"},{"key":"663_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/ncomms1404","volume":"2","author":"B Dai","year":"2011","unstructured":"Dai B, Zhao XF, Mazan-Mamczarz K, Hagner P, Corl S, Bahassi EM, et al. Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma. Nat Commun. 2011;2:402.","journal-title":"Nat Commun"},{"issue":"13","key":"663_CR51","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1182\/blood-2002-04-1078","volume":"100","author":"F Tort","year":"2002","unstructured":"Tort F, Hern\u00e0ndez S, Be\u00e0 S, Mart\u00ednez A, Esteller M, Herman JG, et al. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas. Blood. 2002;100(13):4602\u20138.","journal-title":"Blood"},{"issue":"5","key":"663_CR52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4149\/neo_2011_05_392","volume":"58","author":"O Havranek","year":"2011","unstructured":"Havranek O, Spacek M, Hubacek P, Mocikova H, Markova J, Trneny M, et al. Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma. Neoplasma. 2011;58(5):392\u20135.","journal-title":"Neoplasma"},{"issue":"Suppl 2","key":"663_CR53","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1038\/sj.cdd.4401461","volume":"11","author":"N Kato","year":"2004","unstructured":"Kato N, Fujimoto H, Yoda A, Oishi I, Matsumura N, Kondo T, et al. Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin\u2019s lymphoma cell lines. Cell Death Differ. 2004;11(Suppl 2):S153\u201361.","journal-title":"Cell Death Differ"},{"issue":"4","key":"663_CR54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/jclinpath-2020-206476","volume":"74","author":"Q Ye","year":"2021","unstructured":"Ye Q, Chen H, Wen Z, Guo W, Huang Y, Mo X. Abnormal expression of p-ATM\/CHK2 in nasal extranodal NK\/T cell lymphoma, nasal type, is correlated with poor prognosis. J Clin Pathol. 2021;74(4):223\u20137.","journal-title":"J Clin Pathol"},{"issue":"4","key":"663_CR55","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10637-017-0552-y","volume":"36","author":"J Zhou","year":"2018","unstructured":"Zhou J, Zhang C, Sui X, Cao S, Tang F, Sun S, et al. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK\/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway. Invest New Drugs. 2018;36(4):571\u201380.","journal-title":"Invest New Drugs"},{"issue":"1","key":"663_CR56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ijms23010523","volume":"23","author":"S Ueno","year":"2022","unstructured":"Ueno S, Sudo T, Hirasawa A. ATM: Functions of ATM kinase and its relevance to hereditary tumors. Int J Mol Sci. 2022;23(1):523.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"663_CR57","first-page":"584","volume":"60","author":"H Nakajima","year":"2019","unstructured":"Nakajima H. Genetic abnormalities in AML. Rinsho Ketsueki. 2019;60(6):584\u201393.","journal-title":"Rinsho Ketsueki"},{"issue":"2","key":"663_CR58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"KL Huang","year":"2018","unstructured":"Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. Cell. 2018;173(2):355-70.e14.","journal-title":"Cell"},{"issue":"1","key":"663_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11(1):159.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"663_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jnci\/93.2.121","volume":"93","author":"JH Olsen","year":"2001","unstructured":"Olsen JH, Hahnemann JM, B\u00f8rresen-Dale AL, Br\u00f8ndum-Nielsen K, Hammarstr\u00f6m L, Kleinerman R, et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst. 2001;93(2):121\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"663_CR61","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3109\/08880018.2013.777949","volume":"30","author":"B Bielorai","year":"2013","unstructured":"Bielorai B, Fisher T, Waldman D, Lerenthal Y, Nissenkorn A, Tohami T, et al. Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant. Pediatr Hematol Oncol. 2013;30(6):574\u201382.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"663_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-4608(90)90004-T","volume":"46","author":"M Swift","year":"1990","unstructured":"Swift M, Chase CL, Morrell D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet. 1990;46(1):21\u20137.","journal-title":"Cancer Genet Cytogenet"},{"key":"663_CR63","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1038\/ncomms10086","volume":"6","author":"C Lu","year":"2015","unstructured":"Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MD, et al. Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun. 2015;6:10086.","journal-title":"Nat Commun"},{"issue":"5218","key":"663_CR64","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268(5218):1749\u201353.","journal-title":"Science"},{"issue":"11","key":"663_CR65","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/ajh.26321","volume":"96","author":"ES Martin","year":"2021","unstructured":"Martin ES, Ferrer A, Mangaonkar AA, Khan SP, Kohorst MA, Joshi AY, et al. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes. Am J Hematol. 2021;96(11):1450\u201360.","journal-title":"Am J Hematol"},{"issue":"6","key":"663_CR66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/ejh.12186","volume":"91","author":"T Onoda","year":"2013","unstructured":"Onoda T, Kanno M, Meguro T, Sato H, Takahashi N, Kawakami T, et al. Successful treatment of acute myeloid leukaemia in a patient with ataxia telangiectasia. Eur J Haematol. 2013;91(6):557\u201360.","journal-title":"Eur J Haematol"},{"issue":"9","key":"663_CR67","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3109\/10428194.2011.577256","volume":"52","author":"A Brioli","year":"2011","unstructured":"Brioli A, Parisi S, Iacobucci I, Cavo M, Papayannidis C, Anna Zannetti B, et al. Patient with ataxia telangiectasia who developed acute myeloid leukemia. Leuk Lymphoma. 2011;52(9):1818\u201320.","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"663_CR68","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1200\/JCO.2009.25.5067","volume":"28","author":"CH Lin","year":"2010","unstructured":"Lin CH, Lin WC, Wang CH, Ho YJ, Chiang IP, Peng CT, et al. Child with ataxia telangiectasia developing acute myeloid leukemia. J Clin Oncol. 2010;28(14):e213\u20134.","journal-title":"J Clin Oncol"},{"issue":"2","key":"663_CR69","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7314\/APJCP.2016.17.2.815","volume":"17","author":"M Gorre","year":"2016","unstructured":"Gorre M, Mohandas PE, Kagita S, Cingeetham A, Vuree S, Jarjapu S, et al. Significance of ATM gene polymorphisms in chronic myeloid leukemia\u2014a case control study from India. Asian Pac J Cancer Prev. 2016;17(2):815\u201321.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"663_CR70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.dnarep.2012.10.010","volume":"12","author":"HL Ribeiro","year":"2013","unstructured":"Ribeiro HL, Oliveira RT, Maia AR, Sousa JC, Heredia FF, Magalh\u00e3es SM, et al. ATM polymorphism is associated with low risk myelodysplastic syndrome. DNA Repair (Amst). 2013;12(2):87\u20139.","journal-title":"DNA Repair (Amst)"},{"issue":"7011","key":"663_CR71","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nature02989","volume":"431","author":"K Ito","year":"2004","unstructured":"Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004;431(7011):997\u20131002.","journal-title":"Nature"},{"key":"663_CR72","doi-asserted-by":"crossref","unstructured":"Stetka J, Gursky J, Li\u00f1an Velasquez J, Mojzikova R, Vyhlidalova P, Vrablova L et al. Role of DNA damage response in suppressing malignant progression of chronic myeloid leukemia and polycythemia vera: impact of different oncogenes. Cancers (Basel) 2020;12(4):903.","DOI":"10.3390\/cancers12040903"},{"issue":"43","key":"663_CR73","doi-asserted-by":"publisher","first-page":"E6669","DOI":"10.1073\/pnas.1603876113","volume":"113","author":"MA Gregory","year":"2016","unstructured":"Gregory MA, D\u2019Alessandro A, Alvarez-Calderon F, Kim J, Nemkov T, Adane B, et al. ATM\/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2016;113(43):E6669\u201378.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"663_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00432-015-1995-1","volume":"142","author":"X Liu","year":"2016","unstructured":"Liu X, Liao W, Peng H, Luo X, Luo Z, Jiang H, et al. miR-181a promotes G1\/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM. J Cancer Res Clin Oncol. 2016;142(1):77\u201387.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"663_CR75","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/onc.2008.457","volume":"28","author":"J Grosjean-Raillard","year":"2009","unstructured":"Grosjean-Raillard J, Tailler M, Ad\u00e8s L, Perfettini JL, Fabre C, Braun T, et al. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene. 2009;28(8):1099\u2013109.","journal-title":"Oncogene"},{"issue":"2","key":"663_CR76","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d\u2019Enghien C, Brousse N, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33(2):202\u20138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"663_CR77","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/bjc.2011.266","volume":"105","author":"A Reiman","year":"2011","unstructured":"Reiman A, Srinivasan V, Barone G, Last JI, Wootton LL, Davies EG, et al. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer. 2011;105(4):586\u201391.","journal-title":"Br J Cancer"},{"issue":"10","key":"663_CR78","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/leu.2017.201","volume":"31","author":"G Tiao","year":"2017","unstructured":"Tiao G, Improgo MR, Kasar S, Poh W, Kamburov A, Landau DA, et al. Rare germline variants in ATM are associated with chronic lymphocytic leukemia. Leukemia. 2017;31(10):2244\u20137.","journal-title":"Leukemia"},{"key":"663_CR79","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1182\/blood-2019-127180","volume":"134","author":"BL Lampson","year":"2019","unstructured":"Lampson BL, Tyekucheva S, Shaughnessy CJ, Kim AS, Brown JR. Incidence of germline ATM variants in a consecutive clinical cohort of CLL patients. Blood. 2019;134:1731. https:\/\/doi.org\/10.1182\/blood-2019-127180.","journal-title":"Blood"},{"issue":"10","key":"663_CR80","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1097-1155","volume":"3","author":"S Stilgenbauer","year":"1997","unstructured":"Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med. 1997;3(10):1155\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"663_CR81","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ng0997-96","volume":"17","author":"I Vorechovsk\u00fd","year":"1997","unstructured":"Vorechovsk\u00fd I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, et al. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet. 1997;17(1):96\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"663_CR82","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41467-017-02688-6","volume":"9","author":"A Schrader","year":"2018","unstructured":"Schrader A, Crispatzu G, Oberbeck S, Mayer P, P\u00fctzer S, von Jan J, et al. Actionable perturbations of damage responses by TCL1\/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 2018;9(1):697.","journal-title":"Nat Commun"},{"issue":"3","key":"663_CR83","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41388-020-01542-2","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X, Song Y, Chen W, Ding N, Liu W, Xie Y, et al. Germline variants of DNA repair genes in early onset mantle cell lymphoma. Oncogene. 2021;40(3):551\u201363.","journal-title":"Oncogene"},{"issue":"9","key":"663_CR84","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.leukres.2005.11.010","volume":"30","author":"C Briani","year":"2006","unstructured":"Briani C, Schlotter M, Lichter P, Kalla C. Development of a mantle cell lymphoma in an ATM heterozygous woman after occupational exposure to ionising radiation and somatic mutation of the second allele. Leuk Res. 2006;30(9):1193\u20136.","journal-title":"Leuk Res"},{"issue":"2","key":"663_CR85","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1038\/bcj.2017.15","volume":"7","author":"OC Leeksma","year":"2017","unstructured":"Leeksma OC, de Miranda NF, Veelken H. Germline mutations predisposing to diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(2):e532.","journal-title":"Blood Cancer J"},{"issue":"2","key":"663_CR86","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/gcc.10306","volume":"39","author":"E Liberzon","year":"2004","unstructured":"Liberzon E, Avigad S, Stark B, Zilberstein J, Freedman L, Gorfine M, et al. Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children. Genes Chromosomes Cancer. 2004;39(2):161\u20136.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"663_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9\u201316.","journal-title":"Blood"},{"issue":"7","key":"663_CR88","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41591-021-01411-9","volume":"27","author":"R Saiki","year":"2021","unstructured":"Saiki R, Momozawa Y, Nannya Y, Nakagawa MM, Ochi Y, Yoshizato T, et al. Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis. Nat Med. 2021;27(7):1239\u201349.","journal-title":"Nat Med"},{"issue":"9","key":"663_CR89","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41576-021-00356-6","volume":"22","author":"AJ Silver","year":"2021","unstructured":"Silver AJ, Bick AG, Savona MR. Germline risk of clonal haematopoiesis. Nat Rev Genet. 2021;22(9):603\u201317.","journal-title":"Nat Rev Genet"},{"issue":"7831","key":"663_CR90","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick AG, Weinstock JS, Nandakumar SK, Fulco CP, Bao EL, Zekavat SM, et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020;586(7831):763\u20138.","journal-title":"Nature"},{"issue":"5","key":"663_CR91","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ng.3821","volume":"49","author":"DJ Wright","year":"2017","unstructured":"Wright DJ, Day FR, Kerrison ND, Zink F, Cardona A, Sulem P, et al. Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility. Nat Genet. 2017;49(5):674\u20139.","journal-title":"Nat Genet"},{"key":"663_CR92","doi-asserted-by":"publisher","unstructured":"Slavin TP, Tsang KWK, Longmate J, Castillo D, Herzog J, Qin H et al. Effect of germline ATM mutations on clonal hematopoiesis. J Clin Oncol.\u00a02019;15_suppl:1509. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.1509.","DOI":"10.1200\/JCO.2019.37.15_suppl.1509"},{"key":"663_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24374","author":"L DeRoin","year":"2022","unstructured":"DeRoin L, Cavalcante de Andrade Silva M, Petras K, Arndt K, Phillips N, Wanjari P, et al. Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders. Hum Mutat. 2022. https:\/\/doi.org\/10.1002\/humu.24374.","journal-title":"Hum Mutat"},{"issue":"21","key":"663_CR94","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1182\/blood-2018-01-827881","volume":"131","author":"E Padron","year":"2018","unstructured":"Padron E, Ball MC, Teer JK, Painter JS, Yoder SJ, Zhang C, et al. Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes. Blood. 2018;131(21):2402\u20135.","journal-title":"Blood"},{"key":"663_CR95","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/PO.21.00163","volume":"5","author":"KD Whitaker","year":"2021","unstructured":"Whitaker KD, Obeid E, Daly MB, Hall MJ. Cascade genetic testing for hereditary cancer risk: an underutilized tool for cancer prevention. JCO Precis Oncol. 2021;5:1387\u201396.","journal-title":"JCO Precis Oncol"},{"key":"663_CR96","unstructured":"NCCN. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology.\u00a0Genetic\/familial high-risk assessment: Breast, ovarian, and pancreatic. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf. Accessed 15 Apr\u00a02022"},{"key":"663_CR97","unstructured":"NCCN. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology.\u00a0Genetic\/familial high-risk assessment: Colorectal.\u00a0https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_colon.pdf. Accessed 15 Apr\u00a02022"},{"key":"663_CR98","doi-asserted-by":"crossref","unstructured":"Modlin LA, Flynn J, Zhang Z, Cahlon O, Mueller B, Khan AJ et al.\u00a0Tolerability of Breast Radiotherapy Among Carriers of ATM Germline Variants. 2021;5:227\u201334.","DOI":"10.1200\/PO.20.00334"},{"key":"663_CR99","unstructured":"Auletta JJ, Kou J, Chen M, Shaw BE. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides. 2021. https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.aspx."},{"key":"663_CR100","doi-asserted-by":"crossref","unstructured":"Csizmar CM, Saliba AN, Swisher EM, Kaufmann SH. PARP inhibitors and myeloid neoplasms: a double-edged sword. Cancers (Basel). 2021;13(24):6385.","DOI":"10.3390\/cancers13246385"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-022-00663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-022-00663-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-022-00663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T04:45:51Z","timestamp":1655873151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-022-00663-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s11899-022-00663-7","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"11 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}